Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

KIR ligand incompatibility is not associated with relapse reduction after double umbilical cord blood transplantation.

KIR ligand incompatibility is not associated with relapse reduction after double umbilical cord blood transplantation. Bone Marrow Transplant. 2013 Jul; 48(7):1000-2.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.